HR
Hari Krishnareddy Rachamala
Also known as: Hari Krishnareddy Rachamala
Mayo Clinic, Indian Institute of Chemical Technology, Acharya Nagarjuna University
Research areas: Materials Science · Biomaterials · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Advancements in Transdermal Drug Delivery
0000-0003-0514-4428
Employment
-
Mayo Clinic Postdoctoral fellow2021 - Present
- 2014 - Present
Education
- 2010 - 2012
- 2007 - 2010
Projects & Funding
-
CSIR-SRF Council of Scientific and Industrial Research, India2016 - 2019
-
CSIR-JRF Council of Scientific and Industrial Research, India2014 - 2016
Publications (40)
- Recent Advances in Lipid Nanoparticles for Cancer Vaccines: From Antigen Delivery to Personalized Immunotherapy Save
- The endosomal escape problem solved? New insights into lipid nanoparticle delivery efficiency Save
- Amphiphilic Glycopolymer Nanoparticles for pH-Responsive Paclitaxel Delivery and Enhanced Efficacy in Pancreatic Ductal Adenocarcinoma Therapy Save
- Combining Tumor Treating Fields with Immunotherapy in Pancreatic Ductal Adenocarcinoma: Mechanisms, Preclinical Evidence, and Emerging Therapeutic Synergy Save
- Precise Engineering of Lipid-Based Delivery Systems Using Microfluidics for Biomedical Applications Save
- Translational Advances in Lipid Nanoparticle Drug Delivery Systems for Cancer Therapy: Current Status and Future Horizons Save
- Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma Save
- Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma Save
- Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma Save
- Liposomal Phenylephrine Nanoparticles Enhance the Antitumor Activity of Intratumoral Chemotherapy in a Preclinical Model of Melanoma Save
- SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants Save
- Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe Save
- Combined inhibition of mammalian target of rapamycin (mTOR) and survivin augments radiation therapy in renal cell carcinoma Save
- Importance of Surface-modified Nanocarriers in the Management of Cervical Cancer Save
- Significance of Oct-4 transcription factor as a pivotal therapeutic target for CD44+/24- mammary tumor initiating cells: Aiming at the root of the recurrence Save
- Anticancer properties of ZnO-Curcumin nanocomposite against melanoma cancer and its genotoxicity profiling Save
- In Vitro and In Vivo Anticancer and Genotoxicity Profiles of Green Synthesized and Chemically Synthesized Silver Nanoparticles Save
- Skin-Permeable Nano-Lithocholic Lipidoid Efficiently Alleviates Psoriasis-like Chronic Skin Inflammations Save
- Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System Save
- Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways—In Vitro and In Vivo Studies Save